ALISERTIB for Pancreatic carcinoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 11 adverse event reports in the FDA FAERS database where ALISERTIB was used for Pancreatic carcinoma.
Most Reported Side Effects for ALISERTIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Neutropenia | 16 | 19.1% | 2 | 1 |
| Dehydration | 12 | 14.3% | 1 | 4 |
| Hyponatraemia | 10 | 11.9% | 0 | 2 |
| Malignant neoplasm progression | 10 | 11.9% | 1 | 0 |
| Toxicity to various agents | 10 | 11.9% | 0 | 0 |
| Anaemia | 9 | 10.7% | 3 | 2 |
| Leukopenia | 9 | 10.7% | 0 | 1 |
| Lymphopenia | 9 | 10.7% | 0 | 2 |
| Mucosal inflammation | 9 | 10.7% | 0 | 2 |
| Febrile neutropenia | 8 | 9.5% | 1 | 2 |
| Fatigue | 7 | 8.3% | 2 | 3 |
| Vomiting | 7 | 8.3% | 1 | 1 |
| Diarrhoea | 6 | 7.1% | 1 | 1 |
| Thrombocytopenia | 6 | 7.1% | 2 | 1 |
| Drug ineffective | 5 | 6.0% | 0 | 0 |
Other Indications for ALISERTIB
Other Drugs Used for Pancreatic carcinoma
PACLITAXEL (3,386)
GEMCITABINE (2,706)
IRINOTECAN (2,128)
OXALIPLATIN (1,941)
CAPECITABINE (1,590)
FLUOROURACIL (1,556)
GEMCITABINE\GEMCITABINE (1,434)
ERLOTINIB (1,089)
PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE (722)
LEUCOVORIN (700)